Two Sigma Investments
SRPT icon

Two Sigma Investments’s Sarepta Therapeutics SRPT Stock Holding History

Two Sigma Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,100
Closed -$332K – 3326
2024
Q2 		$332K Buy
+2,100
New +$270K ﹤0.01% 2550
2023
Q4 		– Sell
-8,000
Closed -$970K – 3371
2023
Q3 		$970K Buy
+8,000
New +$904K ﹤0.01% 1952

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Two Sigma Investments's SRPT Position: Q1 2026 in Review

Two Sigma Investments increased its Sarepta Therapeutics (SRPT) stake by 88% in Q1 2026, buying an estimated $41.6M and bringing the position to 4,593,195 shares worth $99.9M. The position accounts for 0.08% of the portfolio, ranked #275.

Two Sigma Investments first reported a position in SRPT in Q3 2015 and has held it in 25 quarters since. The position peaked at $151M in Q1 2023. 341 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Two Sigma Investments held 4,593,195 shares of Sarepta Therapeutics worth $99.9M as of Q1 2026.
  • Two Sigma Investments bought 2,151,740 Sarepta Therapeutics shares in Q1 2026, an estimated $41.6M.
  • Sarepta Therapeutics made up 0.08% of Two Sigma Investments's portfolio in Q1 2026, its #275 holding.
  • Two Sigma Investments first reported a position in Sarepta Therapeutics in Q3 2015 and has held it in 25 quarters since.
  • Two Sigma Investments's Sarepta Therapeutics position peaked at $151M in Q1 2023.
  • 341 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.